David T Gilbertson

Summary

Affiliation: Chronic Disease Research Group
Country: USA

Publications

  1. doi request reprint RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN Electronic address
    Am J Kidney Dis 62:919-28. 2013
  2. pmc Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN 55404, Minnesota, USA
    BMC Nephrol 14:44. 2013
  3. pmc Hemoglobin level variability: associations with mortality
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 206, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 3:133-8. 2008
  4. doi request reprint The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
    Nephrol Dial Transplant 26:2934-9. 2011
  5. pmc Association of provider-patient visit frequency and patient outcomes on hemodialysis
    Yelena Slinin
    Veterans Administration Health Care System, Minneapolis, Minnesota, USA
    J Am Soc Nephrol 23:1560-7. 2012
  6. pmc Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis
    Robert N Foley
    United States Renal Data System, 914 South 8th Street, Suite S 406, Minneapolis, Minnesota, USA
    BMC Nephrol 9:6. 2008
  7. ncbi request reprint Projecting the number of patients with end-stage renal disease in the United States to the year 2015
    David T Gilbertson
    United States Renal Data System Coordinating Center University of Minnesota, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 16:3736-41. 2005
  8. ncbi request reprint Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death
    Areef Ishani
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 253, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 23:1682-9. 2008
  9. ncbi request reprint Clinical factors associated with achieving K/DOQI hemoglobin targets in hemodialysis patients
    Suying Li
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota, USA
    Int Urol Nephrol 35:399-405. 2003
  10. doi request reprint Hemoglobin variability and mortality: confounding by disease severity
    Eric D Weinhandl
    Minneapolis Medical Research Foundation, MN, USA
    Am J Kidney Dis 57:255-65. 2011

Detail Information

Publications72

  1. doi request reprint RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN Electronic address
    Am J Kidney Dis 62:919-28. 2013
    ..Changes in anemia management over the past decade have produced downward shifts in hemoglobin concentrations. We aimed to examine the effect on use of red blood cell (RBC) transfusions...
  2. pmc Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN 55404, Minnesota, USA
    BMC Nephrol 14:44. 2013
    ..We applied three definitions of hyporesponsiveness to a large, national cohort of hemodialysis patients to assess the impact of definition on counts and on characteristics associated with hyporesponsiveness...
  3. pmc Hemoglobin level variability: associations with mortality
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 206, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 3:133-8. 2008
    ..4%; intermediate-intermediate (I-I), 6.0%; high-high (H-H), 2.3%; low-intermediate (L-I), 18.3%; intermediate-high (I-H), 31.7%, and low-high (L-H), 40.2%...
  4. doi request reprint The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
    Nephrol Dial Transplant 26:2934-9. 2011
    ..We aimed to describe vaccination rates between 2003-2005 and to study the effects on outcomes...
  5. pmc Association of provider-patient visit frequency and patient outcomes on hemodialysis
    Yelena Slinin
    Veterans Administration Health Care System, Minneapolis, Minnesota, USA
    J Am Soc Nephrol 23:1560-7. 2012
    ..In summary, greater frequency of provider visits to hemodialysis patients associates with a small but significant reduction in hospitalizations, but it does not consistently associate with lower risk for death...
  6. pmc Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis
    Robert N Foley
    United States Renal Data System, 914 South 8th Street, Suite S 406, Minneapolis, Minnesota, USA
    BMC Nephrol 9:6. 2008
    ....
  7. ncbi request reprint Projecting the number of patients with end-stage renal disease in the United States to the year 2015
    David T Gilbertson
    United States Renal Data System Coordinating Center University of Minnesota, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 16:3736-41. 2005
    ..The financial and human resources that will be needed to care for these patients in 2015 will be considerably greater than in 2005...
  8. ncbi request reprint Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death
    Areef Ishani
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 253, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 23:1682-9. 2008
    ..We aimed to determine the consequences associated with cumulative number of months below target haemoglobin concentrations...
  9. ncbi request reprint Clinical factors associated with achieving K/DOQI hemoglobin targets in hemodialysis patients
    Suying Li
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota, USA
    Int Urol Nephrol 35:399-405. 2003
    ..Few studies have assessed treatable factors associated with achieving the Kidney Disease Outcomes Quality Initiative (K/DOQI) guideline of hemoglobin values of 11 to 12 g/dL in anemic hemodialysis patients...
  10. doi request reprint Hemoglobin variability and mortality: confounding by disease severity
    Eric D Weinhandl
    Minneapolis Medical Research Foundation, MN, USA
    Am J Kidney Dis 57:255-65. 2011
    ..Adequate adjustment for confounding by disease severity is needed to estimate the association of hemoglobin level variability with mortality risk...
  11. doi request reprint Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease
    Allan J Collins
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 53:S71-7. 2009
    ..A CKD screening approach targeting individuals 60 years and older or those with diabetes or hypertension likely would be useful from a public health standpoint...
  12. doi request reprint Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis
    Yelena Slinin
    Veterans Administration Medical Center, Minneapolis, MN 55417, USA
    Am J Kidney Dis 58:583-90. 2011
    ..Few patients receive dietary counseling before end-stage renal disease onset; whether such counseling is associated with improved outcomes is unknown...
  13. pmc Hospital treatment for fluid overload in the Medicare hemodialysis population
    Thomas J Arneson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 5:1054-63. 2010
    ..This study aimed to estimate the magnitude of fluid overload treatment episodes for the Medicare hemodialysis population in hospital settings, including emergency departments...
  14. pmc Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 21:499-506. 2010
    ..These data suggest that increased use of peritoneal dialysis may benefit incident ESRD patients...
  15. pmc Meeting KDOQI guideline goals at hemodialysis initiation and survival during the first year
    Yelena Slinin
    VA Medical Center 111J, One Veteran s Drive, Minneapolis, MN 55417, USA
    Clin J Am Soc Nephrol 5:1574-81. 2010
    ....
  16. doi request reprint Predictors of provider-patient visit frequency during hemodialysis
    Yelena Slinin
    Veterans Administration Health Care System, University of Minnesota, Minneapolis, Minn 55417, USA
    Am J Nephrol 38:91-8. 2013
    ..We aimed to identify patient, provider, and dialysis facility characteristics associated with provider visit frequency...
  17. ncbi request reprint Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    J Am Soc Nephrol 15:174-9. 2004
    ..Hemoglobin levels in U.S. hemodialysis and peritoneal populations are similar. However, erythropoietin doses are dramatically higher in hemodialysis patients...
  18. ncbi request reprint Exceeding hemoglobin target levels in US hemodialysis patients receiving epoetin, 1999 to 2002
    Robert N Foley
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Hemodial Int 11:333-9. 2007
    ..Exceeding hemoglobin level targets has become widespread in the United States and is associated with changes in epoetin dosing practices...
  19. doi request reprint Association of mean weekly epoetin alfa dose with mortality risk in a retrospective cohort study of Medicare hemodialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Minneapolis, MN 55404, USA
    Am J Nephrol 34:298-308. 2011
    ..Appropriately designed observational studies are needed to clarify the association of ESA dosing with mortality risk...
  20. doi request reprint Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005
    Lih Wen Mau
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 55:549-57. 2010
    ..We examined trends in older incident hemodialysis patient characteristics and analyzed first-year post-dialysis therapy initiation medical costs...
  21. ncbi request reprint Time to target haemoglobin concentration (11 g/dl)--risk of hospitalization and mortality among incident dialysis patients
    Areef Ishani
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 22:2247-55. 2007
    ..We aimed to determine if time required to reach 11 g/dl was associated with increased risk of hospitalization or death among incident dialysis patients...
  22. ncbi request reprint Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations
    James P Ebben
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 1:1205-10. 2006
    ..Hemoglobin levels in almost 90% of patients are in some degree of flux at any point in time, and the fluctuation is highly associated with clinical complications and provider practices...
  23. ncbi request reprint Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001
    Haifeng Guo
    United States Renal Data System Coordinating Center, Minneapolis, MN 55404, USA
    Circulation 115:50-8. 2007
    ..Temporal trends regarding the epidemiology of atherosclerotic renovascular disease (ARVD) in dialysis populations are poorly defined...
  24. doi request reprint Hemoglobin level variability: anemia management among variability groups
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minn 55404, USA dgilbertson cdrg org
    Am J Nephrol 30:491-8. 2009
    ..We aimed to describe the influence of anemia management interventions (erythropoiesis-stimulating agents [ESAs], intravenous iron, and transfusions) on hemoglobin variability...
  25. doi request reprint Blood transfusion use in non-dialysis-dependent chronic kidney disease patients aged 65 years and older
    Hassan N Ibrahim
    Minneapolis Medical Research Foundation, Minneapolis, MN, USA
    Nephrol Dial Transplant 24:3138-43. 2009
    ..Their impact on transfusion frequency in elderly chronic kidney disease (CKD) patients aged 65 years and older with non-dialysis-dependent CKD has not been studied...
  26. pmc Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients
    Hassan N Ibrahim
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Clin J Am Soc Nephrol 4:623-9. 2009
    ..The authors aimed to determine prevalence of parenteral iron administration and its contribution to exceeding hemoglobin target levels...
  27. ncbi request reprint Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels
    Tricia L Roberts
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, MN 55404, USA
    Nephrol Dial Transplant 21:1652-62. 2006
    ..Thus, integrating factors predictive of anaemia with actual haemoglobin levels might improve prognostic discrimination...
  28. ncbi request reprint Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States
    Blanche M Chavers
    University of Minnesota, Department of Pediatrics, Mayo Mail Code 491, 420 Delaware Street SE, Minneapolis, MN 5545, USA
    J Am Soc Nephrol 18:952-9. 2007
    ..Pediatric KTx patients require infection surveillance after transplantation...
  29. doi request reprint Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis
    Wendy L St Peter
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Pharmacotherapy 29:154-64. 2009
    ....
  30. ncbi request reprint Anemia and new-onset congestive heart failure in the general Medicare population
    Peter E Sandgren
    Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55404, USA
    J Card Fail 11:99-105. 2005
    ..Anemia is associated with disease severity and prognosis for patients with congestive heart failure (CHF). It is unknown whether anemia is associated with the development of new-onset CHF in the elderly...
  31. ncbi request reprint Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians
    A Marshall McBean
    Division of Health Services Research and Policy, University of Minnesota School of Public Health, MMC 97, Mayo Memorial Building, 420 Delaware St SE, Minneapolis, MN 55455, USA
    Diabetes Care 27:2317-24. 2004
    ..To examine diabetes prevalence, incidence, and mortality from 1993 to 2001 among fee-for-service Medicare beneficiaries > or = 67 years of age...
  32. ncbi request reprint Influenza vaccine delivery and effectiveness in end-stage renal disease
    David T Gilbertson
    United States Renal Data System Coordinating Center and Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 63:738-43. 2003
    ..This report assessed the frequency and effectiveness of influenza vaccination, while also assessing disparities in vaccination rates in the ESRD population...
  33. pmc Provider and care characteristics associated with timing of dialysis initiation
    Yelena Slinin
    Primary Care Service Line, Veterans Administration Health Care System, Minneapolis, Minnesota, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota
    Clin J Am Soc Nephrol 9:310-7. 2014
    ..This study aimed to determine whether provider characteristics and pre-ESRD nephrology care and vascular access are independently associated with higher estimated GFR at initiation...
  34. doi request reprint Impact of Centers for Medicare & Medicaid Services national coverage determination on erythropoiesis-stimulating agent and transfusion use in chemotherapy-treated cancer patients
    Thomas J Arneson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Pharmacoepidemiol Drug Saf 21:857-64. 2012
    ..We aimed to quantify ESA and transfusion use pre-NCD and post-NCD...
  35. doi request reprint An improved comorbidity index for outcome analyses among dialysis patients
    Jiannong Liu
    United States Renal Data System Coordinating Center, 914 South 8th Street, Minneapolis, MN 55404, USA
    Kidney Int 77:141-51. 2010
    ..Our index performance was almost identical to the individual comorbid conditions regarding model fit, predictive ability, and effect on inference, and it outperformed the widely used Charlson Comorbidity Index...
  36. doi request reprint Mortality from cancer among US hemodialysis patients, 1995-2005
    Robert N Foley
    Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Nephrol 31:518-26. 2010
    ..As ESA doses have more than tripled in the USA since ESAs were introduced, we aimed to compare annual trends in cancer-specific mortality rates among incident maintenance hemodialysis patients...
  37. doi request reprint Chronic kidney disease awareness, screening and prevention: rationale for the design of a public education program
    Allan J Collins
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Nephrology (Carlton) 15:37-42. 2010
    ..Such assessment is needed to reduce the high burden of ESRD on national health-care systems, which can only be addressed by early screening and active treatment...
  38. ncbi request reprint Predictors of ESA use in the non-dialysis chronic kidney disease population with anemia
    Allan J Collins
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minn 55404, USA
    Nephron Clin Pract 111:c141-8. 2009
    ..Anemia is a common complication of chronic kidney disease (CKD), but anemia treatment may be less comprehensive than guidelines suggest...
  39. ncbi request reprint The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002
    Robert N Foley
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN 55404, USA
    J Am Soc Nephrol 16:210-8. 2005
    ..Parathyroidectomy rates in U.S. hemodialysis patients increased between 1998 and 2002, a period in which the therapeutic armamentarium for preventing severe hyperparathyroidism expanded considerably...
  40. ncbi request reprint Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators
    Charles A Herzog
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 68:818-25. 2005
    ..The objective of this retrospective cohort study was to determine ICD use in dialysis patients and impact on survival...
  41. ncbi request reprint Anemia and cost in Medicare patients with congestive heart failure
    Craig A Solid
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minnesota, Minneapolis, MN 55404, USA
    Congest Heart Fail 12:302-6. 2006
    ..25 (95% confidence interval, 1.2546-1.2548). Anemia, a common association of CHF in elderly patients, is an antecedent association of increased societal medical expenditure...
  42. ncbi request reprint Perihospitalization hemoglobin-epoetin associations in U.S. hemodialysis patients, 1998 to 2003
    Craig A Solid
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Hemodial Int 11:442-7. 2007
    ..8 in 2003). While time to recovery of prehospitalization hemoglobin levels remained constant year to year, epoetin doses and ERI did not, suggesting that optimum perihospitalization anemia management practices have yet to be determined...
  43. ncbi request reprint Hemodialysis patient outcomes: provider characteristics
    Yelena Slinin
    Veterans Administration Health Care System, Minneapolis, Minn, USA
    Am J Nephrol 39:367-75. 2014
    ..Conclusions: Several characteristics of physicians seeing incident outpatient hemodialysis patients were associated with hospitalization and quality of care, but none with mortality. © 2014 S. Karger AG, Basel. ..
  44. pmc Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN 55404, USA
    J Am Soc Nephrol 23:895-904. 2012
    ..Continued surveillance should strengthen inference about causes of mortality and determine whether treatment effects are homogeneous throughout the dialysis population...
  45. ncbi request reprint Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 50:803-12. 2007
    ..Levocarnitine deficiency in hemodialysis patients is common. Although the effect of intravenous levocarnitine therapy was studied in small trials, the effect on global outcomes in larger populations is unclear...
  46. doi request reprint CKD surveillance using administrative data: impact on the health care system
    Allan J Collins
    US Renal Data System Coordinating Center, University of Minnesota, Minneapolis, MN 55404, USA
    Am J Kidney Dis 53:S27-36. 2009
    ..Long-term trend analyses are needed to determine whether morbidity and mortality rates change based on greater detection and treatment efforts...
  47. pmc Survival of kidney transplantation patients in the United States after cardiac valve replacement
    Alok Sharma
    Department of Internal Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, USA
    Circulation 121:2733-9. 2010
    ..This study aimed to assess survival of US kidney transplantation patients after cardiac valve replacement and to compare associations of valve selection...
  48. ncbi request reprint Body size and outcomes on peritoneal dialysis in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 64:1838-44. 2003
    ..Being overweight is often cited as a relative contraindication to peritoneal dialysis. Our primary objective was to determine whether actual mortality rates support this opinion...
  49. ncbi request reprint EPO adjustments in patients with elevated hemoglobin levels: provider practice patterns compared with recommended practice guidelines
    Allan J Collins
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN, USA
    Am J Kidney Dis 49:135-42. 2007
    ....
  50. ncbi request reprint Use of hospice in the United States dialysis population
    Anne M Murray
    Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 1:1248-55. 2006
    ..Increased hospice use may enable more dialysis patients to die at home, with substantial cost savings. Research regarding additional benefits of hospice care for dialysis patients is needed...
  51. pmc Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?
    Charles A Herzog
    Cardiovascular Special Studies Center, United States Renal Data System, 914 South 8th Street, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 23:2629-33. 2008
    ..We analyzed cause-specific mortality of dialysis patients after coronary revascularization...
  52. doi request reprint The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis
    Allan J Collins
    U S Renal Data System, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 406, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 4:S5-11. 2009
    ..Public health programs, including the new Medicare chronic kidney disease education benefit, are needed to promote better care of patients who may need dialysis to reduce the high morbidity and mortality in the first year...
  53. ncbi request reprint Septicemia in the United States dialysis population, 1991 to 1999
    Robert N Foley
    United States Renal Data System Coordinating Center, 914 South 8th Street, Suite D 206, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 15:1038-45. 2004
    ..7, 2.0, 2.0, and 1.6 after 5 yr, respectively. Septicemia, which is associated with increased cardiovascular and death risk, has become more common in dialysis patients in the United States...
  54. doi request reprint Economic effect of following HbA1c testing practice guidelines in the elderly Medicare population: an instrumental variable analysis
    Suying Li
    United States Renal Data System Coordinating Center, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Med Qual 25:202-10. 2010
    ....
  55. ncbi request reprint Assessment of pure red cell aplasia in US dialysis patients: the limits of the Medicare data
    Allan J Collins
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 43:464-70. 2004
    ..We investigated the frequency of diagnosis codes that include pure red cell aplasia (PRCA) in the Medicare end-stage renal disease data...
  56. ncbi request reprint Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion
    Allan J Collins
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN Department of Medicine, University of Minnesota, Minneapolis, MN Electronic address
    Am J Kidney Dis 63:997-1006. 2014
    ..We examined anemia management trends in hemodialysis patients and risk of red blood cell (RBC) transfusion according to dialysis facility-level hemoglobin concentration...
  57. pmc Long-term survival of dialysis patients with bacterial endocarditis undergoing valvular replacement surgery in the United States
    Maxwell D Leither
    Department of Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis, MN, USA
    Circulation 128:344-51. 2013
    ..The literature is limited on the long-term outcomes of valvular replacement surgery and the choice of prosthesis in dialysis patients with bacterial endocarditis...
  58. doi request reprint Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies
    Jiannong Liu
    United States Renal Data System, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 81:341-50. 2012
    ..Results from the DaVita data were consistent with the simulation. Careful consideration of methodology is needed in observational analyses with time-dependent treatment...
  59. ncbi request reprint Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction
    Areef Ishani
    Section of Nephrology, Department of Medicine, Minneapolis VAMC, One Veterans Drive, Minneapolis, MN 55417, USA
    J Am Coll Cardiol 45:391-9. 2005
    ..We aimed to investigate the impact of angiotensin-converting enzyme inhibitors (ACEIs) on hematocrit values in those with heart failure, and the relationship between incident anemia and mortality...
  60. ncbi request reprint Cancer after kidney transplantation in the United States
    Bertram L Kasiske
    Department of Medicine, Hennepin County Medical Center, Minneapolis, MN, USA
    Am J Transplant 4:905-13. 2004
    ..The rates for most malignancies are higher after kidney transplantation compared with the general population. Cancer should continue to be a major focus of prevention in kidney transplantation...
  61. doi request reprint Long interdialytic interval and mortality among patients receiving hemodialysis
    Robert N Foley
    United States Renal Data System, University of Minnesota, Minneapolis, MN 55404, USA
    N Engl J Med 365:1099-107. 2011
    ..Given these problems, we hypothesized that a long interdialytic interval is associated with adverse events in patients receiving hemodialysis...
  62. ncbi request reprint Predialysis care and dialysis outcomes in hemodialysis patients with a functioning fistula
    Areef Ishani
    Minneapolis VA Health Care System, University of Minnesota, Minneapolis, Minn, USA
    Am J Nephrol 39:238-47. 2014
    ..We investigated types of predialysis care associated with improved patient outcomes in patients initiating dialysis with a fistula and at least 2 years of predialysis care...
  63. ncbi request reprint A comparison of transplant outcomes in peritoneal and hemodialysis patients
    Jon J Snyder
    Minneapolis Medical Research Foundation, 914 S 8th Street, Suite D 253, Minneapolis, MN 55404, USA
    Kidney Int 62:1423-30. 2002
    ..Therefore, we studied the effects of pre-transplant dialysis modality on outcomes in a large United States cohort...
  64. doi request reprint Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure
    Steven R Goldsmith
    Cardiology Division, Hennepin County Medical Center, Minneapolis, Minnesota 55415, USA
    J Card Fail 17:982-9. 2011
    ..This study investigated the renal and neurohormonal effects of loop diuretics, the mixed vasopressin antagonist conivaptan, and the combination in patients with chronic stable HF...
  65. ncbi request reprint Does predialysis nephrology care influence patient survival after initiation of dialysis?
    Samina S Khan
    Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Kidney Int 67:1038-46. 2005
    ....
  66. ncbi request reprint Effect of comorbidity on the increased mortality associated with early initiation of dialysis
    Waqar H Kazmi
    Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 46:887-96. 2005
    ..Whether this is explained by a greater comorbidity burden or detrimental effect of early initiation remains unclear. We thus undertook an evaluation of the impact of comorbidity on the association between GFR at initiation and death...
  67. ncbi request reprint Clinical epidemiology of long-bone fractures in patients receiving hemodialysis
    Thomas M Kaneko
    Department of Neurosurgery, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
    Clin Orthop Relat Res 457:188-93. 2007
    ..Long-bone fractures are common in patients receiving dialysis; their adverse prognostic implications may be linked to major cardiovascular and infectious events...
  68. ncbi request reprint Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis
    Philip A Kalra
    Department of Renal Medicine, Hope Hospital, Salford, United Kingdom
    Kidney Int 68:293-301. 2005
    ..Although atherosclerotic renovascular disease is increasingly recognized in chronic kidney disease, few national level studies have examined its clinical epidemiology...
  69. doi request reprint The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population
    Claudine T Jurkovitz
    Christiana Care Center for Outcomes Research, Christiana Care Health System, Newark, DE 19713, USA
    Am J Kidney Dis 51:S3-12. 2008
    ..This report aims to detail demographic characteristics of KEEP participants and compare them with characteristics of participants in the National Health and Nutrition Examination (NHANES) 1999-2004...
  70. ncbi request reprint Overview of vaccination in chronic kidney disease
    Annamaria T Kausz
    Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
    Adv Chronic Kidney Dis 13:209-14. 2006
    ..However, vaccination rates are relatively low. Given the accumulating evidence of benefit, continuing quality improvement programs focused on increasing vaccination rates in patients with all levels of CKD are needed...
  71. pmc Trends and disparities among diabetes-complicated births in Minnesota, 1993-2003
    Heather M Devlin
    Minnesota Diabetes Program, Minnesota Department of Health, PO Box 64882, St Paul, MN 55164 0882, USA
    Am J Public Health 98:59-62. 2008
    ..8, respectively). Increases were significant in all demographic groups except gestational diabetes among American Indian mothers, and disparities worsened among all groups. Targeted interventions and surveillance improvements are needed...
  72. ncbi request reprint General medical care among patients with chronic kidney disease: opportunities for improving outcomes
    Annamaria T Kausz
    Division of Nephrology, Tufts New England Medical Center, 750 Washington Street, Box 391, Boston, MA 02111, USA
    J Am Soc Nephrol 16:3092-101. 2005
    ..This study provides further evidence that patients with CKD may not be receiving general health and CKD care according to current recommendations...